Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 25, 2017

DrugPatentWatch Database Preview

Dextromethorphan hydrobromide; guaifenesin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for dextromethorphan hydrobromide; guaifenesin and what is the scope of freedom to operate?

Dextromethorphan hydrobromide; guaifenesin
is the generic ingredient in two branded drugs marketed by Reckitt Benckiser, Aurobindo Pharma Ltd, and Actavis Labs Fl, and is included in three NDAs. There are four patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Dextromethorphan hydrobromide; guaifenesin has thirty-six patent family members in nineteen countries.

There are twenty-two drug master file entries for dextromethorphan hydrobromide; guaifenesin. Twenty-nine suppliers are listed for this compound.

Summary for Generic Name: dextromethorphan hydrobromide; guaifenesin

Tradenames:2
Patents:4
Applicants:3
NDAs:3
Drug Master File Entries: see list22
Suppliers / Packagers: see list29
Clinical Trials: see list51
Drug Prices:see low prices
DailyMed Link:dextromethorphan hydrobromide; guaifenesin at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
dextromethorphan hydrobromide; guaifenesin
TABLET, EXTENDED RELEASE;ORAL206941-001Mar 17, 2017OTCNoNo► Subscribe► Subscribe
Reckitt Benckiser
MUCINEX DM
dextromethorphan hydrobromide; guaifenesin
TABLET, EXTENDED RELEASE;ORAL021620-002Apr 29, 2004OTCYesNo6,372,252► SubscribeY ► Subscribe
Reckitt Benckiser
MUCINEX DM
dextromethorphan hydrobromide; guaifenesin
TABLET, EXTENDED RELEASE;ORAL021620-001Apr 29, 2004OTCYesYes6,955,821► SubscribeY ► Subscribe
Actavis Labs Fl
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
dextromethorphan hydrobromide; guaifenesin
TABLET, EXTENDED RELEASE;ORAL091070-001Aug 31, 2015OTCNoNo► Subscribe► Subscribe
Actavis Labs Fl
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
dextromethorphan hydrobromide; guaifenesin
TABLET, EXTENDED RELEASE;ORAL091070-002Aug 31, 2015OTCNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot